The CE approval opens Europe for Cornerstone Robotics as the company expands its global surgical robotics business
Updated
May 29, 2026 4:20 AM
A tray of surgical tools. PHOTO: UNSPLASH
As surgical robotics companies expand beyond domestic markets, regulatory approvals are becoming a critical part of global growth. Companies are no longer competing only on hardware and clinical performance. They are also competing on their ability to enter tightly regulated healthcare systems and build long-term hospital partnerships.
Hong Kong-based Cornerstone Robotics is now moving further into that phase of expansion after its Sentire Endoscopic Surgical System received CE Mark certification under the European Union’s Medical Device Regulation framework.
The approval allows the company to commercialize the system across European markets for minimally invasive procedures in general surgery, gynecology, thoracic surgery and urology. For surgical robotics companies, regulatory approvals often represent more than product validation. They also determine market access, hospital adoption opportunities and long-term commercial scale.
Cornerstone Robotics has already been building clinical operations in the UK ahead of the approval. Since 2025, the company has worked with Portsmouth Hospitals University NHS Trust on clinical investigations involving the Sentire Surgical System. According to the company, the system has been used across procedures involving urology, gynecology and gastrointestinal surgery. The company says the clinical investigation helped generate real-world data to support physician training, research and future adoption efforts.
Alongside the regulatory approval, Cornerstone Robotics is also expanding its local operations in Europe. The company established a UK subsidiary in 2025 and has been developing training, clinical support and after-sales service capabilities for hospitals using the system.
That operational buildout reflects a larger challenge inside surgical robotics. Hospitals adopting robotic systems often require ongoing clinical training, technical support and workflow integration alongside the hardware itself.
Cornerstone Robotics says its strategy centers around vertically integrated development across engineering, software, imaging and robotics systems. The company argues that this structure gives it greater control over product development, supply chain management and long-term operational stability.
Professor Samuel Au, Founder and CEO of Cornerstone Robotics, said: "Receiving CE Certification marks a major milestone in Cornerstone Robotics' evolution from a technology innovator to a global clinical solutions provider. From our first clinical investigation in Portsmouth, UK, to achieving European regulatory approval, each step of the journey reflects our commitment to proprietary innovation, product excellence, and clinical value. Looking ahead, we will continue expanding into key global markets and partnering with leading medical institutions to bring high-quality surgical robotic solutions to more physicians and patients worldwide."
The CE approval also comes several months after the company completed an oversubscribed financing round of approximately US$200 million in November 2025.
The funding and regulatory expansion together signal how surgical robotics companies are increasingly entering a more commercially focused stage of growth. Beyond research and development, companies are now investing more heavily in regulatory approvals, hospital partnerships, physician training and international operational infrastructure as competition expands across global healthcare markets.
Keep Reading
Quantara AI launches a continuous platform designed to estimate the financial impact of cyber risk as companies move beyond periodic assessments
Updated
March 17, 2026 1:02 AM
A person tightrope walking between two cliffs. PHOTO: UNSPLASH
Cyber risk is increasingly treated as a financial issue. Boards want to know how much a cyber incident could cost the company, how it could affect earnings, and whether current security spending is justified.
Yet many organizations still measure cyber risk through periodic reviews. These assessments are often conducted once or twice a year, supported by consultants and spreadsheet models. By the time the report reaches senior leadership, the company’s systems may have changed and new threats may have emerged. The way risk is measured does not always match how quickly it evolves.
This gap is where Quantara AI is positioning its new platform. Quantara AI, a Boise-based cybersecurity startup, has introduced what it describes as the industry’s first persistent AI-powered cyber risk solution. The system is designed to run continuously rather than rely on occasional assessments.
The company’s core argument is straightforward: not every security weakness carries the same financial consequence. Instead of ranking issues only by technical severity, the platform analyzes active threats, identifies which company systems are exposed, and estimates how much money a successful attack could cost. It uses statistical models, including Value at Risk (VaR), to calculate potential losses. It also estimates how specific security improvements could reduce that projected loss.
The timing aligns with a broader market shift. International Data Corporation (IDC) projects that by 2028, 40% of enterprises will adopt AI-based cyber risk quantification platforms. These tools convert security data into financial estimates that can guide budgeting and investment decisions. The forecast reflects growing pressure on security leaders to present risk in terms that boards and regulators understand.
Traditional compliance and risk management systems often focus on meeting regulatory standards. Vulnerability management programs typically score weaknesses based on technical characteristics. Consultant-led risk studies provide detailed analysis, but they are usually performed at set intervals. In fast-changing threat environments, that model can leave decision-makers working with outdated information.
Quantara’s platform attempts to replace that periodic process with continuous measurement. It brings together threat data, internal system information and financial modeling in one system. The goal is to show, at any given time, which specific weaknesses could lead to the largest financial losses.
Cyber risk quantification as a concept is not new. What is changing is the expectation that these calculations be updated regularly and tied directly to financial decision-making. As cyber incidents carry clearer monetary consequences, companies are looking for ways to measure exposure with greater precision.
The broader question is whether enterprises will shift fully toward continuous, AI-driven risk analysis or continue relying on periodic external assessments. What is clear is that cybersecurity discussions are moving closer to financial reporting — and tools that estimate potential loss in dollar terms are becoming central to that shift.